Vera Therapeutics (VERA) Other Working Capital Changes (2022 - 2026)
Vera Therapeutics (VERA) posted Other Working Capital Changes of -$182000.0 for Q1 2026, down 82.0% on a QoQ basis from -$100000.0 in Q4 2025, and up 53.81% year-over-year from -$118330.0 in Q1 2025.
Vera Therapeutics (VERA) Other Working Capital Changes (2022 - 2026) Analysis & Trends
Vera Therapeutics' Other Working Capital Changes history runs 5 years deep, the most recent figure standing at -$182000.0 for Q1 2026.
- Quarterly Other Working Capital Changes rose 53.81% year-over-year to -$182000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$1.3 million (up 41.27% YoY) and the FY2025 annual result came in at -$1.5 million, up 38.39% from the prior year.
- Other Working Capital Changes was -$182000.0 for Q1 2026 at Vera Therapeutics, down from -$100000.0 in the prior quarter.
- Across five years, Other Working Capital Changes topped out at $5.9 million in Q1 2025 and bottomed at -$6.0 million in Q2 2025.
- A 5-year average of $71294.1 and a median of -$9000.0 in 2024 frame the typical range for Other Working Capital Changes.
- Annual changes were most pronounced in 2023 — Other Working Capital Changes retreated 8.63% — and 2025, when it soared 81.1%.
- Vera Therapeutics' Other Working Capital Changes stood at -$693000.0 in 2022, then grew by 6.35% to -$649000.0 in 2023, then climbed by 18.49% to -$529000.0 in 2024, then surged by 81.1% to -$100000.0 in 2025, then sank by 82.0% to -$182000.0 in 2026.
- Business Quant data shows VERA's Other Working Capital Changes at -$182000.0 in Q1 2026, -$100000.0 in Q4 2025, and -$520000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Vera Therapeutics | 2.60 Bn | 2.60 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Mar 31, 2026 | -182,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Dec 31, 2025 | -100,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Sep 30, 2025 | -520,000.00 |
| Jun 30, 2025 | -469,000.00 |
| Jun 30, 2025 | -469,000.00 |
| Jun 30, 2025 | -469,000.00 |
| Mar 31, 2025 | -394,000.00 |
| Mar 31, 2025 | -394,000.00 |
| Mar 31, 2025 | -394,000.00 |
| Dec 31, 2024 | -529,000.00 |
| Dec 31, 2024 | -529,000.00 |
| Dec 31, 2024 | -529,000.00 |
| Sep 30, 2024 | -618,000.00 |
| Sep 30, 2024 | -618,000.00 |